AVERT | International stroke rehabilitation database available for research projects
The study investigators consider that A Very Early Rehabilitation Trial (AVERT) provides a large international stroke rehabilitation database and is an important resource for ongoing research.
What is AVERT?
AVERT is an international trial focussed on commencing frequent, higher dose, mobilisation within 24 hours of stroke and compared to usual stroke unit care (Lancet 2015). The study was a parallel-group, single blind, randomised controlled trial. 2104 patients were recruited between July 2006 and October 2014 from 56 acute stroke units in Australia, New Zealand, Singapore, Malaysia and the United Kingdom. Data collected included: stroke screening, baseline demographic and mobilisation intervention. Three and 12 month outcomes included disability, mobility, health related quality of life, mood, cognition and costs. Serious and non-serious adverse events were collected. The trial protocol is available to download. The trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12606000185561.
The study investigators encourage and solicit project proposals with the aim to publication. There are Procedures and Processes in place to permit access to study data for project analysis and publication through a review and approval process under the governance of the AVERT Management Committee. Under these Procedures and Processes, any investigator at any University or Research Institute can propose a project. When approved, one or more members of the AVERT management committee will be nominated as a co-investigator/s and collaborate on the project.
If you are interested in accessing the AVERT database, please familiarise yourself with the Procedures and Processes and data collected. Then complete and submit an Expression of Interest Form and a two page summary Curriculum Vittae to email@example.com.
The AVERT Trial Collaboration group, Bernhardt J, Langhorne P, Lindley RI, Thrift AG, Ellery F, Collier J, Churilov L, Moodie M, Dewey H, Donnan G. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015; 386: 46-55. doi: 10.1016/S0140-6736(15)60690-0
Rethnam V, Bernhardt J, Dewey H, Moodie M, Johns H, Gao L, Collier J, Ellery F, Churilov L, on behalf of AVERT Trial Collaboration group. Utility-weighted modified Rankin Scale: still too crude to be a truly patient-centric primary outcome measure? Int J Stroke. 2019: 1-10. doi: https://doi.org/10.1177/1747493019830583
Gao L, Sheppard L, Wu O, Churilov L, Mohebbi M, Collier J, Bernhardt J, Ellery F, Dewey H, Moodie M, The AVERT Trial Collaboration group. Economic evaluation of a phase III randomised controlled trial of very early mobilisation after stroke (AVERT). BMJ Open. 2019; 9: e026230. doi: 10.1136/bmjopen-2018-026230
Cumming TB, Bernhardt J, Lowe D, Collier J, Dewey H, Langhorne P, Thrift AG, Green A, Mohanraj R, Kramer SF, Churilov L, Linden T, and on behalf of the AVERT Trial Collaboration group. Early mobilization after stroke is not associated with cognitive outcome. Findings from AVERT Stroke. 2018; 49: 2147-2154. doi: 10.1161/STROKEAHA.118.022217
Langhorne P, Wu O, Rodgers H, Ashburn A, Bernhardt J. A Very Early Rehabilitation Trial after stroke (AVERT): a phase III, multicentre, randomised controlled trial. Health Technology Assessment. 2017; 21: 1-120. doi: 10.3310/hta21540
Sheppard L, Dewey H, Bernhardt J, Collier JM, Ellery F, Churilov L, Tay-Teo K, Wu O, Moodie M, on behalf of the AVERT Trial Collaboration Group. Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 hours of stroke onset with usual stroke unit care. Int J Stroke. 2016; 11: 492-494. doi: 10.1177/1747493016632254
Bernhardt J, Churilov L, Ellery F, Collier J, Chamberlain J, Langhorne P, Lindley RI, Moodie M, Dewey H, Thrift AG, Donnan G, on behalf of the AVERT Collaboration Group. Pre-specified dose-response analysis for A Very Early Rehabilitation Trial (AVERT). Neurology. 2016; 86: 2138-2145. doi: 10.1212/WNL.0000000000002459
Bernhardt J, Raffelt A, Churilov L, Lindley RI, Speare S, Ancliffe J, Katijjahbe MA, Hameed S, Lennon S, McRae A, Tan D, Quiney J, Williamson HC, Collier J, Dewey HM, Donnan GA, Langhorne P, Thrift AG, on behalf of the AVERT Trialists' Collaboration. Exploring threats to generalisability in a large international rehabilitation trial (AVERT). BMJ Open. 2015; 5: e008378. doi: 10.1136/bmjopen-2015-008378
Bernhardt J, Lindley RI, Lalor E, Ellery F, Chamberlain J, Van Holsteyn J, Collier JM, Dewey HM, Parsons B, Moodie M, Lennon S, Donnan GA, Thrift AG, Churilov A, Langhorne P, on behalf of the AVERT Collaboration Group. AVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff. BMJ. 2015; 351: h6432. doi: 10.1136/bmj.h6432. doi: 10.1136/bmj.h6432
Bernhardt J, Churilov L, Dewey H, Lindley R, Moodie M, Collier J, Langhorne P, Thrift A, Donnan G, for the AVERT Collaborators. Statistical Analysis Plan (SAP) for A Very Early Rehabilitation Trial (AVERT): An international trial to determine the efficacy and safety of commencing out of bed standing and walking training (very early mobilisation) within 24 h of stroke onset vs usual stroke unit care. Int J Stroke. 2015; 10: 23-24. doi: 10.1111/ijs.12423
Latest Florey news for stroke
Mobile Stroke Unit hits the streets of Melbourne
Australia’s first ever dedicated stroke ambulance will hit the road in Melbourne next year to provide the quickest possible diagnosis and reatment for patients suffering a life threatening stroke.
The Florey proposes Australian-first youth stroke recovery service
The Herald Sun reports that young stroke survivors would be funnelled into clinical trials for new treatments and recovery interventions linked to other young patients, and helped back into the workforce as part of an Australian-first one-stop shop.
Brain health affects all Australians. You can support our research by making a donation or a bequest.